{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T15:26:45Z","timestamp":1790350005913,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,4,12]],"date-time":"2015-04-12T00:00:00Z","timestamp":1428796800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13023-015-0259-0","type":"journal-article","created":{"date-parts":[[2015,4,11]],"date-time":"2015-04-11T01:37:14Z","timestamp":1428716234000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Diagnosis, quality of life, and treatment of patients with Hunter syndrome in the French healthcare system: a retrospective observational study"],"prefix":"10.1186","volume":"10","author":[{"given":"Nathalie","family":"Guffon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9n\u00e9dicte","family":"Heron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Chabrol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Feillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Montauban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassili","family":"Valayannopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,12]]},"reference":[{"key":"259_CR1","first-page":"3421","volume-title":"The Metabolic and Molecular Bases of Inherited Disease","author":"EF Neufeld","year":"2001","unstructured":"Neufeld EF, Muenzer J. The mucopolysaccharidoses. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The Metabolic and Molecular Bases of Inherited Disease, vol. III. 8th ed. New York: McGraw-Hill; 2001. p. 3421\u201352.","edition":"8"},{"key":"259_CR2","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00431-007-0635-4","volume":"167","author":"JE Wraith","year":"2008","unstructured":"Wraith JE, Scarpa M, Beck M, Bodamer OA, De Meirleir L, Guffon N, et al. Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy. Eur J Pediatr. 2008;167:267\u201377.","journal-title":"Eur J Pediatr"},{"key":"259_CR3","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1136\/jmg.19.6.408","volume":"19","author":"ID Young","year":"1982","unstructured":"Young ID, Harper PS, Newcombe RG, Archer IM. A clinical and genetic study of Hunter\u2019s syndrome. 2. Differences between the mild and severe forms. J Med Genet. 1982;19:408\u201311.","journal-title":"J Med Genet"},{"key":"259_CR4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/1750-1172-8-101","volume":"8","author":"M Raluy-Callado","year":"2013","unstructured":"Raluy-Callado M, Chen WH, Whiteman DA, Fang J, Wiklund I. The impact of Hunter syndrome (mucopolysaccharidosis type II) on health-related quality of life. Orphanet J Rare Dis. 2013;8:101.","journal-title":"Orphanet J Rare Dis"},{"key":"259_CR5","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/01.gim.0000232477.37660.fb","volume":"8","author":"J Muenzer","year":"2006","unstructured":"Muenzer J, Wraith JE, Beck M, Giugliani R, Harmatz P, Eng CM, et al. A phase II\/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome). Genet Med. 2006;8:465\u201373.","journal-title":"Genet Med"},{"key":"259_CR6","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00431-011-1606-3","volume":"171","author":"J Muenzer","year":"2012","unstructured":"Muenzer J, Bodamer O, Burton B, Clarke L, Frenking GS, Giugliani R, et al. The role of enzyme replacement therapy in severe Hunter syndrome\u2014an expert panel consensus. Eur J Pediatr. 2012;171:181\u20138.","journal-title":"Eur J Pediatr"},{"key":"259_CR7","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/gim.2013.162","volume":"16","author":"R Giugliani","year":"2014","unstructured":"Giugliani R, Hwu WL, Tylki-Szymanska A, Whiteman DA, Pano A. A multicenter, open-label study evaluating safety and clinical outcomes in children (1.4-7.5\u00a0years) with Hunter syndrome receiving idursulfase enzyme replacement therapy. Genet Med. 2014;16:435\u201341.","journal-title":"Genet Med"},{"key":"259_CR8","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/GIM.0b013e318206786f","volume":"13","author":"J Muenzer","year":"2011","unstructured":"Muenzer J, Beck M, Giugliani R, Suzuki Y, Tylki-Szymanska A, Valayannopoulos V, et al. Idursulfase treatment of Hunter syndrome in children younger than 6\u00a0years: results from the Hunter Outcome Survey. Genet Med. 2011;13:102\u20139.","journal-title":"Genet Med"},{"key":"259_CR9","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ejmg.2010.07.013","volume":"53","author":"C Alcalde-Martin","year":"2010","unstructured":"Alcalde-Martin C, Muro-Tudelilla JM, Cancho-Candela R, Gutierrez-Solana LG, Pintos-Morell G, Marti-Herrero M, et al. First experience of enzyme replacement therapy with idursulfase in Spanish patients with Hunter syndrome under 5\u00a0years of age: case observations from the Hunter Outcome Survey (HOS). Eur J Med Genet. 2010;53:371\u20137.","journal-title":"Eur J Med Genet"},{"key":"259_CR10","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1111\/j.1651-2227.2011.02385.x","volume":"101","author":"A Tylki-Szymanska","year":"2012","unstructured":"Tylki-Szymanska A, Jurecka A, Zuber Z, Rozdzynska A, Marucha J, Czartoryska B. Enzyme replacement therapy for mucopolysaccharidosis II from 3\u00a0months of age: a 3-year follow-up. Acta Paediatr. 2012;101:e42\u20137.","journal-title":"Acta Paediatr"},{"key":"259_CR11","first-page":"175","volume":"109","author":"N Guelbert","year":"2011","unstructured":"Guelbert N, Amartino H, Arberas C, Azar N, Bay L, Faiboim A, et al. Guideline for diagnosis, follow-up and treatment of mucopolysaccharidoses type II or Hunter disease. Arch Argent Pediatr. 2011;109:175\u201381.","journal-title":"Arch Argent Pediatr"},{"key":"259_CR12","doi-asserted-by":"crossref","first-page":"e1228","DOI":"10.1542\/peds.2008-0999","volume":"124","author":"J Muenzer","year":"2009","unstructured":"Muenzer J, Beck M, Eng CM, Escolar ML, Giugliani R, Guffon NH, et al. Multidisciplinary management of Hunter syndrome. Pediatrics. 2009;124:e1228\u201339.","journal-title":"Pediatrics"},{"key":"259_CR13","first-page":"218","volume-title":"ECDEU: Assessment Manual for Psychopharmacology (Revised)[DHEW Publ No ADM 76\u2013338]","author":"U.S. Department of Health","year":"1976","unstructured":"U.S. Department of Health. ECDEU: Assessment Manual for Psychopharmacology (Revised)[DHEW Publ No ADM 76\u2013338]. Washington, DC: U.S. Department of Health; 1976. p. 218\u201322."},{"key":"259_CR14","unstructured":"KIDSCREEN-27. [ http:\/\/www.kidscreen.org\/english\/questionnaires\/kidscreen-27-short-version\/ ]"},{"key":"259_CR15","volume-title":"The KIDSCREEN Questionnaires. Quality of life questionnaires for children and adolescents","author":"KIDSCREEN Group T","year":"2006","unstructured":"KIDSCREEN Group T. The KIDSCREEN Questionnaires. Quality of life questionnaires for children and adolescents. Lengerich: Pabst Science Publishers; 2006."},{"key":"259_CR16","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1007\/s11136-007-9240-2","volume":"16","author":"U Ravens-Sieberer","year":"2007","unstructured":"Ravens-Sieberer U, Auquier P, Erhart M, Gosch A, Rajmil L, Bruil J, et al. The KIDSCREEN-27 quality of life measure for children and adolescents: psychometric results from a cross-cultural survey in 13 European countries. Qual Life Res. 2007;16:1347\u201356.","journal-title":"Qual Life Res"},{"key":"259_CR17","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1586\/14737167.5.3.353","volume":"5","author":"U Ravens-Sieberer","year":"2005","unstructured":"Ravens-Sieberer U, Gosch A, Rajmil L, Erhart M, Bruil J, Duer W, et al. KIDSCREEN-52 quality-of-life measure for children and adolescents. Expert Rev Pharmacoecon Outcomes Res. 2005;5:353\u201364.","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"259_CR18","volume-title":"EQ-5D Health Questionnaire","author":"EQ Group","year":"2009","unstructured":"Group EQ. EQ-5D Health Questionnaire. Rotterdam: EuroQol Group; 2009."},{"key":"259_CR19","doi-asserted-by":"crossref","first-page":"e377","DOI":"10.1542\/peds.2007-1350","volume":"121","author":"R Martin","year":"2008","unstructured":"Martin R, Beck M, Eng C, Giugliani R, Harmatz P, Munoz V, et al. Recognition and diagnosis of mucopolysaccharidosis II (Hunter syndrome). Pediatrics. 2008;121:e377\u201386.","journal-title":"Pediatrics"},{"key":"259_CR20","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1750-1172-6-72","volume":"6","author":"M Scarpa","year":"2011","unstructured":"Scarpa M, Almassy Z, Beck M, Bodamer O, Bruce IA, De Meirleir L, et al. Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare disease. Orphanet J Rare Dis. 2011;6:72.","journal-title":"Orphanet J Rare Dis"},{"key":"259_CR21","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s10545-011-9378-5","volume":"35","author":"A Keilmann","year":"2012","unstructured":"Keilmann A, Nakarat T, Bruce IA, Molter D, Malm G. Hearing loss in patients with mucopolysaccharidosis II: data from HOS\u2013the Hunter Outcome Survey. J Inherit Metab Dis. 2012;35:343\u201353.","journal-title":"J Inherit Metab Dis"},{"key":"259_CR22","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00003446-198407000-00009","volume":"5","author":"JE Peck","year":"1984","unstructured":"Peck JE. Hearing loss in Hunter\u2019s syndrome\u2013mucopolysaccharidosis II. Ear Hear. 1984;5:243\u20136.","journal-title":"Ear Hear"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-015-0259-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-015-0259-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-015-0259-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T18:50:52Z","timestamp":1553626252000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ojrd.com\/content\/10\/1\/43"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,12]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["259"],"URL":"https:\/\/doi.org\/10.1186\/s13023-015-0259-0","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,12]]},"article-number":"43"}}